NCT00784459View on ClinicalTrials.gov

The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

February 29, 2012

Conditions

Atopic Asthma

Interventions

DRUG

abatacept

Treatment with abatacept, 10 mg/kg IV, for 5 doses.

DRUG

Placebo

Treatment with Placebo, IV

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00784459 - The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics | Biotech Hunter | Biotech Hunter